Jason Kelly

Chief Executive Officer, Ginkgo Bioworks

Co-Founder and Chief Executive Officer of Ginkgo Bioworks. Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapeutics discovery.

订阅更新

每周更新全球议程内容

© 2022 World Economic Forum

隐私政策和服务条款